Skip to content
Clinical Trials – home

Arq National Psychotrauma Centre

Research siteFast reply

The Netherlands Nienoord 5, 1112 XE Diemen, The Netherlands

  • 1 trial recruiting
  • Post-traumatic stress disorder
  • Adult patients

About Specializations

Arq National Psychotrauma Centre in Diemen, The Netherlands specialises in clinical trials of conditions such as Post-traumatic stress disorder, and other specialisations. This site conducts important research.

Main research areas of the site

Psychiatry and Mental Health

The medical center is at the forefront of innovative treatments in psychiatry and mental health, focusing on groundbreaking therapies for complex conditions. The center's research is particularly concentrated on exploring novel therapeutic approaches for posttraumatic stress disorder (PTSD), a condition that significantly impacts mental well-being.

  • MDMA-Assisted Psychotherapy
  • Innovative Treatment Modalities
  • Therapeutic Interventions for PTSD

Through its pioneering work, the center is contributing to the development of new treatment paradigms that aim to alleviate symptoms and improve the quality of life for individuals with treatment-refractory PTSD.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Nienoord 51112 XE DiemenThe Netherlands
Recruiting now
1 trial
Conditions studied
1

More sites in DiemenThe Netherlands

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study on MDMA-Assisted Therapy for Patients with Treatment-Resistant PTSD

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Midomafetamine Hydrochloride
  • Sponsor:ARQ National Psychotrauma Centrum

Feasibility and Safety of PEX010 Psilocybin Capsules (5 mg and 25 mg) in Military Veterans with Posttraumatic Stress Disorder

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
  • Sponsor:ARQ National Psychotrauma Centrum
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.